CompareMarketResearchRequest a sample
Home / Healthcare / Touch Activated Phlebotomy Devices

Healthcare · Market report

Touch Activated Phlebotomy Devices Market Size, Share and Forecast 2026-2036

The global touch activated phlebotomy devices market is worth USD 72 mn in 2026 and is forecast to reach USD 377 mn by 2036, growing at a 18.0% CAGR. United States is the largest country market and Touch-activated capillary collection is the largest by technology segment.

USD 72 mnMarket size 2026
USD 377 mnForecast 2036
18.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global touch activated phlebotomy devices market is worth USD 72 mn in 2026 and is forecast to reach USD 377 mn by 2036, growing at a 18.0% CAGR. United States is the largest country market and Touch-activated capillary collection is the largest by technology segment.

ScopeSingle-use devices that collect capillary blood painlessly from the upper arm with a push-button or touch-activated action, used in clinical trials, direct-to-consumer testing and clinic blood draws.
IndustryHealthcare
Value 2025USD 60 mn
Value 2026USD 72 mn
Value 2036USD 377 mn
CAGR 2026-203618.0%
Volume 20261,212,121 devices
Volume 20367,014,782 devices
Average price 2026USD 59.4 per device
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Touch Activated Phlebotomy Devices market size and forecast, 2026-2036

Exhibit 1The global touch activated phlebotomy devices market is forecast to grow from USD 72 mn in 2026 to USD 377 mn by 2036, more than five times its 2026 sizeGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 18.0%
Touch Activated Phlebotomy Devices market value, 2025 to 2036Market value by year. 2025: USD 60 mn; 2026: USD 72 mn; 2027: USD 85 mn; 2028: USD 100 mn; 2029: USD 118 mn; 2030: USD 140 mn; 2031: USD 165 mn; 2032: USD 194 mn; 2033: USD 229 mn; 2034: USD 271 mn; 2035: USD 319 mn; 2036: USD 377 mn. Compound annual growth rate 2026 to 2036: 18.0%.202572 mn2026165 mn2031377 mn203618.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 72 mn
2027USD 85 mn
2028USD 100 mn
2029USD 118 mn
2030USD 140 mn
2031USD 165 mn
2032USD 194 mn
2033USD 229 mn
2034USD 271 mn
2035USD 319 mn
2036USD 377 mn

Touch Activated Phlebotomy Devices market segmentation

By technology

Exhibit 2Touch-activated capillary collection is the largest segment by technology, with 68.0% of 2026 revenueEstimated share of 2026 global revenue, by technology
Touch Activated Phlebotomy Devices market share by technology, 2026Share of 2026 revenue by technology. Touch-activated capillary collection: 68.0%; Microneedle and dried blood spot devices: 20.0%; Other minimally invasive collection: 12.0%.Touch-activated capillary collection68.0%Microneedle and dried blood spot devices20.0%Other minimally invasive collection12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Touch-activated capillary collection68.0%73.4%USD 49 mn18.9%
Microneedle and dried blood spot devices20.0%18.2%USD 14 mn16.9%
Other minimally invasive collection12.0%8.4%USD 8.6 mn13.9%

By use

Exhibit 3Direct-to-consumer and retail testing adds the most revenue by use, growing from USD 23 mn in 2026 to USD 149 mn by 2036Estimated revenue in USD by use, 2026 and 2036 forecast
Touch Activated Phlebotomy Devices market by use, 2026 and 2036Revenue by use in 2026 and 2036. Decentralised clinical trials: USD 27 mn in 2026, USD 150 mn in 2036, change +449%; Direct-to-consumer and retail testing: USD 23 mn in 2026, USD 149 mn in 2036, change +548%; Clinical diagnostics: USD 22 mn in 2026, USD 77 mn in 2036, change +259%.20262036 forecastChangeDecentralised clinical trials+449%27 mn150 mnDirect-to-consumer and retail testing+548%23 mn149 mnClinical diagnostics+259%22 mn77 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Decentralised clinical trials38.0%39.9%USD 27 mn18.6%
Direct-to-consumer and retail testing32.0%39.6%USD 23 mn20.5%
Clinical diagnostics30.0%20.6%USD 22 mn13.6%

By sample volume

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Under 100 microlitre42.0%46.0%USD 30 mn19.1%
100 to 500 microlitre38.0%36.0%USD 27 mn17.4%
Above 500 microlitre20.0%18.0%USD 14 mn16.8%

By user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Patients at home30.0%38.0%USD 22 mn20.8%
Phlebotomists40.0%34.0%USD 29 mn16.1%
Research sites30.0%28.0%USD 22 mn17.2%

By test

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Routine chemistry38.0%34.0%USD 27 mn16.7%
Haematology26.0%24.0%USD 19 mn17.1%
Specialty and biomarker36.0%42.0%USD 26 mn19.8%

Top 25 countries for touch activated phlebotomy devices by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 96.0% of 2026 revenue and the 25 countries below together hold 98.4%.

Exhibit 4United States is the largest country market at USD 48 mn in 2026, and the three largest countries hold 77.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Touch Activated Phlebotomy Devices market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 48 mn, 66.0%; United Kingdom: USD 4.3 mn, 6.0%; Germany: USD 3.6 mn, 5.0%; Canada: USD 2.9 mn, 4.0%; Australia: USD 2.2 mn, 3.0%; France: USD 2.2 mn, 3.0%; Japan: USD 2.2 mn, 3.0%; Netherlands: USD 1.4 mn, 2.0%; Sweden: USD 1.4 mn, 2.0%; Switzerland: USD 1.4 mn, 2.0%.United States48 mn 66.0%United Kingdom4.3 mn 6.0%Germany3.6 mn 5.0%Canada2.9 mn 4.0%Australia2.2 mn 3.0%France2.2 mn 3.0%Japan2.2 mn 3.0%Netherlands1.4 mn 2.0%Sweden1.4 mn 2.0%Switzerland1.4 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 48 mn66.0%USD 260 mn18.5%
2United KingdomUSD 4.3 mn6.0%USD 22 mn17.6%
3GermanyUSD 3.6 mn5.0%USD 17 mn16.5%
4CanadaUSD 2.9 mn4.0%USD 14 mn17.4%
5AustraliaUSD 2.2 mn3.0%USD 11 mn17.6%
6FranceUSD 2.2 mn3.0%USD 9.8 mn16.3%
7JapanUSD 2.2 mn3.0%USD 9.0 mn15.4%
8NetherlandsUSD 1.4 mn2.0%USD 6.8 mn16.8%
9SwedenUSD 1.4 mn2.0%USD 6.8 mn16.8%
10SwitzerlandUSD 1.4 mn2.0%USD 6.8 mn16.8%
11ItalyUSD 0.38 mn0.5%USD 1.8 mn16.6%
12SpainUSD 0.23 mn0.3%USD 1.1 mn16.4%
13South KoreaUSD 0.17 mn0.2%USD 0.79 mn16.9%
14BrazilUSD 0.14 mn0.2%USD 0.90 mn20.8%
15BelgiumUSD 0.12 mn0.2%USD 0.53 mn16.4%
16DenmarkUSD 0.10 mn0.1%USD 0.45 mn16.2%
17AustriaUSD 86 thousand0.1%USD 0.41 mn17.0%
18NorwayUSD 79 thousand0.1%USD 0.38 mn16.9%
19IrelandUSD 72 thousand0.1%USD 0.34 mn16.8%
20IsraelUSD 65 thousand0.09%USD 0.45 mn21.4%
21SingaporeUSD 65 thousand0.09%USD 0.41 mn20.4%
22TaiwanUSD 58 thousand0.08%USD 0.26 mn16.4%
23IndiaUSD 58 thousand0.08%USD 0.38 mn20.7%
24PolandUSD 50 thousand0.07%USD 0.34 mn21.0%
25TurkeyUSD 50 thousand0.07%USD 0.34 mn21.0%
Rest of worldUSD 1.2 mn1.6%USD 5.5 mn16.8%
Exhibit 5United States and United Kingdom account for 75% of the USD 305 mn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Touch Activated Phlebotomy Devices market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 72 mn. United States: +USD 212 mn; United Kingdom: +USD 18 mn; Germany: +USD 13 mn; Canada: +USD 11 mn; Australia: +USD 8.8 mn; 20 other countries: +USD 38 mn; Rest of world: +USD 4.3 mn. Market value 2036: USD 377 mn.Market value 202672 mnUnited States+212 mnUnited Kingdom+18 mnGermany+13 mnCanada+11 mnAustralia+8.8 mn20 other countries+38 mnRest of world+4.3 mnMarket value 2036377 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Becton Dickinson
  • YourBio Health

Group 2: Regional and specialist players

  • Tasso
  • Neoteryx
  • Babson Diagnostics

Group 3: Emerging and niche players

  • Loop Medical
  • Capitainer
  • Spot On Sciences
  • Trajan Scientific and Medical

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the touch activated phlebotomy devices market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 18.0% is calculated from the resulting values.

The market is divided by technology, by use, by sample volume, by user, by test. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the touch activated phlebotomy devices market?

The global touch activated phlebotomy devices market is estimated at USD 60 mn in 2025 and USD 72 mn in 2026.

How fast will the touch activated phlebotomy devices market grow?

It is forecast to reach USD 377 mn by 2036, a compound annual growth rate of 18.0% from 2026, an increase of USD 305 mn.

Which country is the largest market for touch activated phlebotomy devices?

United States is the largest market by revenue at USD 48 mn in 2026, 66.0% of the global total. The three largest countries together hold 77.0%.

Which country is growing fastest?

Among the ten largest markets, United States is growing fastest at 18.5% a year from 2026 to 2036.

Which touch activated phlebotomy devices segment is largest?

In the by technology split, Touch-activated capillary collection is the largest segment with 68.0% of 2026 revenue.

Who are the leading touch activated phlebotomy devices companies?

Global leaders include Becton Dickinson, YourBio Health.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Tissue Engineering Track and Trace →

All Healthcare markets →

Request a sample